Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tra

Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)

The Middle East and Africa carbapenem-based antibiotics market is expected to reach US$ 297.20 million by 2028 from US$ 237.42 million in 2021; it is estimated to grow at a CAGR of 3.3% from 2021-2028.

The market's growth is attributed to factors such as the rising prevalence of bacterial infections and increasing private and public partnerships of leading pharmaceutical players. However, the tedious and expensive process of developing antibiotics is expected to restrain the market's growth during the forecast period.

Technological developments in the pharmaceutical industry led to drastic evolution and better treatment. The pharmaceutical industry has incorporated intelligent technologies such as deep learning, artificial intelligence (AI), and machine learning to develop new antibiotics. Researchers are working to establish tools and platforms for identifying new antibiotics. It is expected that the novel technologies in new antibiotic discoveries are supposed to change the overall antibiotics market. However, developing antibiotics for gram-negative bacteria is challenging, as various drugs are still developing.

The major challenge for the development of antibiotics is the limited permeability of molecules across the bacterial envelope. However, gram-negative bacteria have nutrient-specific protein channels (porins) that restrict the permeability of non-essential molecules, including antibiotics. Permeability has allowed researchers to develop a new platform called computational antibiotic screening (CLASP), which helps identify potential drug molecules through porins.

CLASP has the advantage of coarse grain (CG) resolution, advanced sampling techniques, and a parallel computing environment that maximizes its performance. It provides complete thermodynamic and kinetic results of a potential drug molecule under study in a few hours. It helps in understanding or identifying small molecule libraries that yield structure-property relationships to discover antibiotics with high permeability. Thus, it is expected that CLASP will accelerate the new antibiotic drug for gram-negative bacterial infections, thus further leading to significant market growth.

Also, generic versions are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. As a result, companies are accelerating generic drug production and driving the Middle East carbapenem-based antibiotics market.

Middle East & Africa Carbapenem-Based Antibiotics Market Revenue and Forecast to 2028 (US$ million)

MIDDLE EAST & AFRICA CARBAPENEM-BASED ANTIBIOTICS MARKET SEGMENTATION

By Type

Meropenem Imipenem Doripenem Tebipenem Others By Indication

Bacterial Meningitis Acute Pelvic Infections Respiratory Tract Infections Intra-Abdominal Infections Urinary Tract Infections Others By Distribution Channel

Hospital Pharmacies Retail Pharmacies Online Pharmacies By Country

Saudi Arabia South Africa UAE Rest of Middle East & Africa Company Profiles

ACS Dobfar S.p.A Gland Pharma Limited Merck & Co., Inc. Savior Lifetec Pfizer Inc. Spero Therapeutics

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa carbapenem-based antibiotics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa carbapenem-based antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.